Heptamidine dimethanesulfonate
Heptamidine dimethanesulfonate is a potent S100B inhibitor (Kd 6.9 μM) derived from Pentamidine, showing selective cytotoxicity against S100B-overexpressing melanoma cells. It is also utilized as a research tool in studies of Myotonic Dystrophy (DM), applicable in both in vitro and in vivo experimental models.
Product Specifications
CAS Number
161374-55-6
Product Name Alternative
Cell, dystrophy, cancer, Calcium-Binding, calcium-binding protein S100B, inhibit, Myotonic, Inhibitor, Heptamidine, Heptamidine dimethanesulfonate, HeLa, melanoma, S100B, SBi4211, SBi-4211, SBi4211 dimethanesulfonate, SBi 4211
Purity
97.80% (May vary between batches)
Solubility
H2O:8.33 mg/mL (14.86 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (3.57 mM) ; DMSO:70 mg/mL (124.85 mM)
Smiles
CS (O) (=O) =O.CS (O) (=O) =O.NC (=N) c1ccc (OCCCCCCCOc2ccc (cc2) C (N) =N) cc1
Molecular Formula
C23H36N4O8S2
Molecular Weight
560.68
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1238258 Inquire
Recombinant Agrobacterium radiobacter Protease HtpX homolog (htpX)
Sign In for Pricing
View Details